Speciality Medicines (BOM:544738) Total Receivables: ₹361.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544738 Speciality Medicines Ltd BOM:544738
21 GF Score
Price ₹156.65
! 3 Warning Signs
View Full Analysis

What is Speciality Medicines Total Receivables?

Speciality Medicines BOM:544738 -6.76% 21 Total Receivables is ₹361.0 Mil as of Mar. 2026. GuruFocus rates BOM:544738 with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Speciality Medicines's Total Receivables for the quarter that ended in Mar. 2026 was ₹361.0 Mil.

Speciality Medicines Total Receivables Related Terms

Speciality Medicines Total Receivables Historical Data

* Premium members only.

The historical data trend for Speciality Medicines's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Speciality Medicines Total Receivables Chart

Speciality Medicines Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
25.91 55.28 107.46 96.26 361.05

Speciality Medicines Semi-Annual Data
Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables 25.91 55.28 107.46 96.26 361.05
BOM:544738
21GF Score
Speciality Medicines Ltd BOM:544738
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Speciality Medicines Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹361.0 Mil mean?
Speciality Medicines (BOM:544738) has a Total Receivables of ₹361.0 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Speciality Medicines and its competitors.
Is Speciality Medicines' Total Receivables too high?
Speciality Medicines' current Total Receivables is ₹361.0 Mil. Overall, Speciality Medicines has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Speciality Medicines' Total Receivables compare to ZTS?
Speciality Medicines' Total Receivables of ₹361.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Speciality Medicines and its competitors. Speciality Medicines's current Total Receivables is ₹361.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Speciality Medicines stock overvalued right now?
Speciality Medicines (BOM:544738) has a current Total Receivables of ₹361.0 Mil. The current Total Receivables is ₹361.0 Mil. Speciality Medicines' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Speciality Medicines (BOM:544738), the current Total Receivables is ₹361.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Speciality Medicines Business Description

Address 20 Mahakali Caves Road, Unit 27, Ground Floor, Andheri Sainath Premises Co Soc, Andheri (East, Mumbai, MH, IND, 400093
Speciality Medicines Ltd is engaged in the marketing and distribution of finished formulations of specialty pharmaceutical products, comprising oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases. Its product range includes various dosage forms such as tablets, capsules, syrups, injections, infusions, inhalers, sprays, and topical formulations. The company operates through two business models: (a) Manufacturing, through contract manufacturing basis, and (b) Marketing and distribution of specialty pharmaceutical products sourced from manufacturers. The majority of the company's revenue is derived from the sale of its projects, mainly through exports to other countries.
21GF Score

Get the complete analysis for BOM:544738

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹156.65
Price